Tag: Announces
Kyowa Kirin Announces Mogamulizumab Received Positive CHMP Opinion for the Treatment of Mycosis Fungoides and Sézary Syndrome

Kyowa Kirin Announces Mogamulizumab Received Positive CHMP Opinion for the Treatment of Mycosis Fungoides and Sézary Syndrome

TOKYO, September 21, 2018 /PRNewswire/ -- If approved, mogamulizumab would be the first biologic agent targeting CCR4 to be available for patients in Europe.   Kyowa Hakko ...

Lees verder
LGC Capital Announces Planting of First Cannabis Crop in Italy and Important Updates on its Evolution Bnk Transaction

LGC Capital Announces Planting of First Cannabis Crop in Italy and Important Updates on its Evolution Bnk Transaction

MONTREAL, August 21, 2018 /PRNewswire/ -- /NOT FOR DISTRIBUTION IN THE UNITED STATES/  Ramping up production in Italy, LGC Capital Ltd. ("LGC") is pleased to announce that ...

Lees verder
Honor Play Announces Joint Strategic Partnerships with Top Mobile Games PUBG MOBILE and Asphalt 9: Legends at Gamescom

Honor Play Announces Joint Strategic Partnerships with Top Mobile Games PUBG MOBILE and Asphalt 9: Legends at Gamescom

Game-specific customization of Honor Play will be available on PUBG MOBILE and Gameloft's Asphalt 9: Legends for revolutionary gaming experience COLOGNE, Germany, Aug. 22, ...

Lees verder
StorageCraft Announces ShadowXafe – Next Generation Data Protection Solution for Total Business Continuity

StorageCraft Announces ShadowXafe – Next Generation Data Protection Solution for Total Business Continuity

Powerful and Flexible SLA-Driven Data Protection for Virtual and Physical Environments with Orchestrated One-Click Cloud Recovery Eliminates Downtime LONDON, Aug. 20, 2018 ...

Lees verder
Venture Global LNG Announces Additional Private Placement Funding of $160 Million: Aggregate Funding Total Reaches $630 Million

Venture Global LNG Announces Additional Private Placement Funding of $160 Million: Aggregate Funding Total Reaches $630 Million

ARLINGTON, Virginia, Aug. 16, 2018 /PRNewswire/ -- Venture Global LNG, Inc. announces that it has raised additional private capital of approximately $160 million from large ...

Lees verder
Empire State Realty Trust Announces Annual "ESB Moment" Photo Contest With $5,000 Cash Prize

Empire State Realty Trust Announces Annual "ESB Moment" Photo Contest With $5,000 Cash Prize

Entries Will Now Also be Accepted from Canada and the United Kingdom NEW YORK, Aug. 13, 2018 /PRNewswire/ -- Empire State Realty Trust, Inc. today announced its seventh ...

Lees verder
Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome

Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome

TOKYO, August 8, 2018 /PRNewswire/ -- - Poteligeo has been approved for the treatment of the two most common types of Cutaneous T-cell lymphoma (CTCL) in ...

Lees verder
The Stars Group Announces Second Quarter 2018 Earnings Release Conference Call and Webcast Details and Changes in Reporting Segments

The Stars Group Announces Second Quarter 2018 Earnings Release Conference Call and Webcast Details and Changes in Reporting Segments

TORONTO, August 2, 2018 /PRNewswire/ -- The Stars Group Inc. today announced that it will release its financial results for the second quarter ended June 30, 2018 and ...

Lees verder
Adlai Nortye announces the publication of the Biomarker Analysis From BERIL-1, the Buparlisib study in HNSCC

Adlai Nortye announces the publication of the Biomarker Analysis From BERIL-1, the Buparlisib study in HNSCC

HANGZHOU, China, July 30, 2018 /PRNewswire/ -- Adlai Nortye Corporation, a leading biotech company in China, today announced a biomarker analysis publication by the ...

Lees verder
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile

Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile

TAIPEI, Taiwan, July 26, 2018 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today that it has successfully completed a Phase 1 multiple ...

Lees verder
BizPress.nl